---
{"dg-publish":true,"permalink":"/USMLE/GI/Antiemetics/"}
---

![L24761.jpg](/img/user/appendix/L24761.jpg)![Pasted image 20240503202021.png](/img/user/appendix/Pasted%20image%2020240503202021.png)
# [[USMLE/Neurology/Neurotransmitters\|Dopamine]] receptor antagonists
---
## Metoclopramide
- Mechanism
	- <span style="background:rgba(240, 200, 0, 0.2)">D2 antagonist, [[USMLE/Neurology/Neurotransmitters\|serotonin]] receptor antagonist</span> 
	- <span style="background:rgba(240, 200, 0, 0.2)">Central antiemetic effect at the area postrema</span>
	- Peripheral antiemetic effect in the gastrointestinal tract (<span style="background:rgba(240, 200, 0, 0.2)">prokinetic effect</span>); causes increase in:
		- Gastric contractions
		- Duodenal and jejunal motility
		- Resting tone of the lower esophageal sphincter
	- Together with decreased pylorus sphincter activity allows food to pass more quickly through the stomach and the small intestine
	- No influence on colon motility
- Clinical use
	- <span style="background:rgba(240, 200, 0, 0.2)">Prokinetic effect used to treat diabetic and postsurgery gastroparesis (delayed gastric emptying)</span>
	- Hyperemesis gravidarum
	- Persistent [[USMLE/GI/Gastroesophageal reflux disease\|GERD]]
